Blood eosinophil levels in newborns with severe indirect hyperbilirubinemia treated with phototherapy
- PMID: 25562019
- PMCID: PMC4276580
Blood eosinophil levels in newborns with severe indirect hyperbilirubinemia treated with phototherapy
Abstract
Objective: Newborns who suffer from jaundice and/or receive phototherapy (PT) are at a higher risk of developing asthma. In this study we aimed to investigate the relationship between bilirubin and peripheral eosinophil counts in newborns with severe hyperbilirubinemia needing PT.
Methods: In this study, a retrospective analysis was performed on 306 newborns with severe hyperbilirubinemia with gestational age ≥35 weeks (Group 1) and the control group consisted of 295 age and gender-matched newborns (Group 2). Total serum bilirubin, hemoglobin, albumin, leucocyte and eosinophil counts before and after PT were recorded from medical charts. Findings : All the patients in Group 1 received phototherapy and 77 (25.2%) of them needed exchange transfusion (ET). Before receiving PT, the patients in Group 1 had lower levels of Hb and higher levels of total serum bilirubin and lymphocytes than those in Group 2 although there was no statistically significant difference with regard to peripheral eosinophil counts. Eosinophils were detected to be numerically lower in Group 1. Higher bilirubin subgroups had also lower eosinophil counts. The patients in Group 1 had lower levels of Hb, leucocyte, albumin and higher levels of eosinophil following PT.
Conclusion: Peripheral eosinophil count may be affected by bilirubin levels and/or phototherapy. There is a need for further clinical research based on different models.
Keywords: Newborn; Jaundice; Phototheraphy; Eosinophil; Asthma.
Figures
Similar articles
-
The effects of phototherapy on eosinophil and eosinophilic cationic protein in newborns with hyperbilirubinemia.Fetal Pediatr Pathol. 2014 Jun;33(3):151-6. doi: 10.3109/15513815.2014.883456. Epub 2014 Feb 14. Fetal Pediatr Pathol. 2014. PMID: 24527832
-
Eosinophil count and tumor necrosis factor α in response to phototherapy treatment of neonatal hyperbilirubinemia: a cross sectional study.Ital J Pediatr. 2022 Jun 20;48(1):103. doi: 10.1186/s13052-022-01302-w. Ital J Pediatr. 2022. PMID: 35725569 Free PMC article.
-
Effect of Neonatal Phototherapy on Eosinophil Levels in Nonsevere Hyperbilirubinemia.Am J Perinatol. 2020 Jul;37(9):929-932. doi: 10.1055/s-0039-1691746. Epub 2019 May 24. Am J Perinatol. 2020. PMID: 31127603
-
[Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].Arch Pediatr. 2014 Sep;21(9):976-83. doi: 10.1016/j.arcped.2014.02.005. Epub 2014 Aug 11. Arch Pediatr. 2014. PMID: 25125032 Review. French.
-
Hyperbilirubinemia in preterm infants in Japan: New treatment criteria.Pediatr Int. 2018 Aug;60(8):684-690. doi: 10.1111/ped.13635. Pediatr Int. 2018. PMID: 29906300 Review.
Cited by
-
Peripheral blood biomarkers as differential diagnostic markers of disease severity in neonates with hyperbilirubinemia.Heliyon. 2024 Dec 17;11(1):e41299. doi: 10.1016/j.heliyon.2024.e41299. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39811285 Free PMC article.
-
Blue-Green (~480 nm) versus Blue (~460 nm) Light for Newborn Phototherapy-Safety Considerations.Int J Mol Sci. 2022 Dec 27;24(1):461. doi: 10.3390/ijms24010461. Int J Mol Sci. 2022. PMID: 36613904 Free PMC article. Review.
References
-
- Gotlib J. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Acta Haematol. 2005;114(1):7–25. - PubMed
-
- Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235(4792):1043–6. - PubMed
-
- Khan NM, Poduval TB. Immunomodulatory and immunotoxic effects of bilirubin:molecular mechanism. J Leukoc Biol. 2011;90(5):997–1015. - PubMed
LinkOut - more resources
Full Text Sources